Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development.
- DOI
- 10.1016/j.ebiom.2022.104065
- Published
- 2022 Jun
- Container
- EBioMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2022.104065,
title = {Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development.},
author = {Gaur AH and Panetta JC and Smith AM and Dallas RH and Freeman BB 3rd and Stewart TB and Tang L and John E and Branum KC and Patel ND and Ost S and Heine RN and Richardson JL and Hammill JT and Bebrevska L and Gusovsky F and Maki N and Yanagi T and Flynn PM and McCarthy JS and Chalon S and Guy RK},
year = {2022},
journal = {EBioMedicine},
doi = {10.1016/j.ebiom.2022.104065},
url = {https://doi.org/10.1016/j.ebiom.2022.104065}
}RIS
TY - JOUR TI - Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development. AU - Gaur AH AU - Panetta JC AU - Smith AM AU - Dallas RH AU - Freeman BB 3rd AU - Stewart TB AU - Tang L AU - John E AU - Branum KC AU - Patel ND AU - Ost S AU - Heine RN AU - Richardson JL AU - Hammill JT AU - Bebrevska L AU - Gusovsky F AU - Maki N AU - Yanagi T AU - Flynn PM AU - McCarthy JS AU - Chalon S AU - Guy RK PY - 2022 JO - EBioMedicine DO - 10.1016/j.ebiom.2022.104065 UR - https://doi.org/10.1016/j.ebiom.2022.104065 ER -
APA
AH, G., JC, P., AM, S., RH, D., 3rd, F. B., TB, S., L, T., E, J., KC, B., ND, P., S, O., RN, H., JL, R., JT, H., L, B., F, G., N, M., T, Y., PM, F., JS, M., S, C., & RK, G. (2022). Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2022.104065
Source records
- pubmed · retrieved 2026-09-25T23:41:54.806Z